|
|
Approximately 25% of all reported medication errors result from some kind of name confusion.
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.
Medication errors are three times higher among children and infants than with adults.
In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.